IDO1 and neoplasm: A significant decrease in IDO1 expression can be observed in the tumor when inhibiting glutamine metabolism, accompanied by a robust reversal of the Kyn/Trp ratio [26], which led to the prediction that the increased IDO1 expression activates the immunosuppressive effect of MDSCs in TME.